Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2020 and Full Year Ending March 31, 2021
July 31, 2020
Share
Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the six months ending September 30, 2020 and full year ending March 31, 2021. For the six months ending September 30, 2020, the company expects net sales of JPY 3,970 million. Operating profit is expected to be JPY 520 million. Profit is expected to be JPY 400 million. Earnings per share is expected to be JPY 13.92.
For the full year ending March 31, 2021, the company expects net sales of JPY 8,400 million. Operating profit is expected to be JPY 1,160 million. Profit is expected to be JPY 860 million. Earnings per share is expected to be JPY 29.94.
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.
DAIKEN MEDICAL CO., LTD. 
